Kodiak Sciences Inc.

About Kodiak Sciences Inc.

Kodiak Sciences is a biopharmaceutical company dedicated to researching, developing, and commercializing next-generation therapies for retinal diseases. Their mission is to prevent and treat the leading causes of blindness in the developed world.

Products & Services

Tarcocimab Tedromer:An anti-VEGF Antibody Biopolymer Conjugate (ABC) for high-prevalence retinal vascular diseases like Wet AMD, Diabetic Retinopathy, and Retinal Vein Occlusion. It offers strong immediacy and high durability, with Phase 3 studies completed and ongoing.

KSI-501:A first-in-class bispecific Antibody Biopolymer Conjugate (ABC) targeting retinal inflammation and vascular permeability for high-prevalence retinal vascular diseases. It addresses higher efficacy and durability, currently in Phase 3.

KSI-101:A first-in-class bispecific protein for macular edema secondary to inflammation (MESI). It targets IL-6-mediated inflammation and VEGF-mediated vascular permeability, with no current intravitreal biologic therapies for this condition, in Phase 3.

Specialties

Retinal Disease Therapies Antibody Biopolymer Conjugate (ABC) Platform Ocular Disease Treatment High-Prevalence Retinal Vascular Diseases Macular Edema Secondary to Inflammation (MESI)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering of Common Stock T: - FT: Public Offering of Common Stock	A: 160000000 MR: - FA: $160 million FAN: 160000000	D: 2025-12-16 FD: 2025-12-16	4 investors

Public Offering of Common Stock Latest

2025-12-16

$160.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

V

Victor Perlroth

Chairman and Chief Executive Officer

J

John Borgeson

Chief Financial Officer

D

Dolly S. Chang

Chief Scientific Officer

A

Almas Qudrat

Chief Quality Officer

P

Pablo Velazquez-Martin

Chief Medical Officer

L

Laurent Ducry

Senior Vice President, Biologics Development and Manufacturing

View 12 more team members with Pro

Unlock Full Team Directory

Recent News